Strategic Plan
-
First VICC cancer patient treated with new immunotherapy
For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system. Read MoreMar 3, 2016
-
Study seeks to ease pediatric HIV infection rates in Africa
Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce. Read MoreMar 3, 2016
-
10 Questions with flutist Rama Kumaran
Meet Rama Kumaran, a sophomore who was the winner of the National Flute Association’s Young Artist Competition this summer and was featured on National Public Radio’s “From the Top” series at age 16. He talks Harry Potter fan fiction, his strategies to connect with an audience and what drew him… Read MoreMar 1, 2016
-
Compassion key to VUMC’s strategic mission: Balser
“Service through compassion” was the theme of the Winter 2016 Clinical Enterprise Leadership Assembly at Vanderbilt University Medical Center (VUMC). Read MoreFeb 18, 2016
-
Study explores less invasive way to monitor colorectal cancer
Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States. Read MoreFeb 18, 2016
-
Liver transplant program celebrates 25 years of care
Twenty-five years ago, Julie Damon’s family was preparing to say their goodbyes. Comatose and on life support at Vanderbilt University Medical Center (VUMC) with liver failure, the options for the 45-year-old wife and mother of two were slipping away. Read MoreFeb 18, 2016
-
Study leads to new heart transplant decision support tool
Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant. Read MoreFeb 18, 2016
-
Cardiologist Hood keeps patients’ best interests at heart
When Rob Hood, M.D., began practicing cardiology 30 years ago he could not have imagined that fitness would one day be measured on a device worn around his wrist. Read MoreFeb 11, 2016
-
Transplant Center initiative seeks to boost cancer education
Lindsay Ramsey Smith, MSN, R.N., a quality consultant for the Vanderbilt Transplant Center (VTC), recently uncovered some interesting data that sparked a center-wide improvement project. Read MoreFeb 11, 2016
-
Slight chemical change may improve TB treatments: study
One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered. Read MoreFeb 11, 2016
-
Study identifies potential colon cancer biomarker
A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut. Read MoreFeb 11, 2016
-
Prostate cancer survivors’ risk of heart disease studied
The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression. Read MoreFeb 4, 2016
-
VICC joins other major cancer centers in HPV vaccine campaign
In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer. Read MoreFeb 4, 2016
-
Grant spurs research into trauma-induced vision loss
Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide. Read MoreFeb 4, 2016
-
10 Questions with improv comedian Megan Ward
Meet Megan Ward: the actress behind Vanderbilt Off-Broadway’s Elle Woods. Well known on campus as an improv comedian, Pi Phi President and VP of the Business Careers and Entertainment Club, she dons a blonde ‘do and pink heels for her starring performance this weekend. Amidst a crazy rehearsal schedule, the… Read MoreFeb 3, 2016
-
Findings offer new insight on how cell division proteins work
A family of proteins with critical roles in cell division, synaptic transmission and cell migration don’t all function the way scientists thought they did, according to two new studies led by Vanderbilt researchers. Read MoreJan 28, 2016
-
Cochlear implant’s success is music to patient’s ears
Sidney Kleinman is living proof that you’re never too old to have your hearing restored. Read MoreJan 28, 2016
-
Autism study links sensory difficulties, serotonin system
Vanderbilt researchers have established a link between the neurotransmitter serotonin and certain behaviors of some children with autism spectrum disorder (ASD), a link that may lead to new treatments for ASD. Read MoreJan 28, 2016
-
Resolving the food-energy-water trilemma
A computer model has been developed that provides new insights into the food-energy-water nexus and can help resource managers around the world do a better job of weighing food and energy tradeoffs when water is scarce. Read MoreJan 25, 2016
-
Using MRI to assess myelin health
Vanderbilt investigators report an improved model for estimating brain health, using MRI. Read MoreJan 25, 2016